Neonatal Screening for Dependents of Active-Duty Military Personnel

PEDIATRICS ◽  
1992 ◽  
Vol 90 (1) ◽  
pp. 130-131
Author(s):  
EDWARD R. B. MCCABE
Keyword(s):  
Newborn Screening ◽  
Military Personnel ◽  
Neonatal Screening ◽  
Screening Program ◽  
Active Duty ◽  
Newborn Screening Program ◽  
Active Duty Military ◽  
The Us ◽  
Made In

In Reply.— COL Pettett is to be applauded for bringing attention to the issue of newborn screening among dependents of military personnel. He provides the opportunity to reemphasize several points made in the statement from the Committee on Genetics1 including: the need for a standardized policy or program for these dependents, particularly those born outside the US; the value of dedicated regionalized labonatory facilities in a newborn screening program; and the components that require consideration in any such policy or program, which include not only the laboratory, but also educational, administrative, follow-up, management, and evaluative components.

Neonatal Screening for Dependents of Active-Duty Military Personnel

PEDIATRICS ◽  
1992 ◽  
Vol 90 (1) ◽  
pp. 129-130
Author(s):  
GARY PETTETT
Keyword(s):  
Newborn Screening ◽  
Military Personnel ◽  
Neonatal Screening ◽  
The United States ◽  
Active Duty ◽  
Inherited Disorders ◽  
Active Duty Military ◽  
Increased Risk ◽  
Recent Statement ◽  
February Issue

To the Editor.— In the February issue of Pediatrics the Committee on Genetics issued their most recent statement and recommendations on newborn screening for metabolic/inherited disorders.1 Within the text of this statement there is incorrect information concerning newborn screening for dependents of active-duty military personnel. In the commentary on universal screening (Goal 21p346) the Committee reports: The absence of a standardized neonatal screening policy or program for dependents of the United States Uniformed Services also placed them at increased risk for failure to be screened, particularly those born outside the US.

scholarly journals Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences

2020 ◽  
Vol 6 (2) ◽  
pp. 35 ◽  
Author(s):  
Yvonne Kellar-Guenther ◽  
Sarah McKasson ◽  
Kshea Hale ◽  
Sikha Singh ◽  
Marci K. Sontag ◽  
...  
Keyword(s):  
Newborn Screening ◽  
Screening Program ◽  
Muscular Atrophy ◽  
Survival Curve ◽  
Type I ◽  
Mucopolysaccharidosis Type I ◽  
Newborn Screening Program ◽  
Mps I ◽  
Insight Into

Data were collected from 39 newborn screening (NBS) programs to provide insight into the time and factors required for implementing statewide screening for Pompe, Mucopolysaccharidosis type I (MPS I), adrenoleukodystrophy (ALD), and Spinal Muscular Atrophy (SMA). Newborn screening program readiness to screen statewide for a condition was assessed using four phases: (1) approval to screen; (2) laboratory, follow-up, and information technology capabilities; (3) education; and (4) implementation of statewide newborn screening. Seventeen states (43.6%) reached statewide implementation for at least one new disorder. Those states reported that it took 28 months to implement statewide screening for Pompe and MPS I, 30.5 months for ALD, and 20 months for SMA. Using survival curve analysis to account for states still in progress, the estimated median time to statewide screening increased to 75 months for Pompe and 66 months for MPS I. When looking at how long each readiness component took to complete, laboratory readiness was one of the lengthier processes, taking about 39 months. Collaboration with other NBS programs and hiring were the most frequently mentioned facilitators to implementing newborn screening. Staffing or inability to hire both laboratory and follow-up staff was the most frequently mentioned barrier.

scholarly journals Cost Analysis of Health Examination Screening Program for Ischemic Heart Disease in Active-Duty Military Personnel in the Middle-Income Country

2021 ◽  
Vol 9 ◽  
Author(s):  
Radoje Simic ◽  
Nenad Ratkovic ◽  
Viktorija Dragojevic Simic ◽  
Zorica Savkovic ◽  
Mihajlo Jakovljevic ◽  
...  
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Arterial Hypertension ◽  
Military Personnel ◽  
Screening Program ◽  
Active Duty ◽  
Ischemic Heart ◽  
Health Examination ◽  
Periodic Health Examination ◽  
Active Duty Military

Cardiovascular diseases, including ischemic heart disease, are the most common causes of morbidity and death in the world, including Serbia, as a middle-income European country. The aim of the study was to determine the costs of preventive examinations for ischemic heart disease in active-duty military personnel, as well as to assess whether this was justified from the point of view of the limited health resources allocated for the treatment of the Republic of Serbia population. This is a retrospective cost-preventive study which included 738 male active-duty military personnel, aged from 23 to 58. The costs of primary prevention of ischemic heart disease in this population were investigated. Out of 738 subjects examined, arterial hypertension was detected in 101 subjects (in 74 of them, arterial hypertension was registered for the first time, while 27 subjects were already subjected to pharmacotherapy for arterial hypertension). Average costs of all services during the periodic-health-examination screening program were €76.96 per subject. However, average costs of all services during the periodic-health-examination screening program for patients with newfound arterial hypertension and poorly regulated arterial hypertension were €767.54 per patient and €2,103.63 per patient, respectively. Since periodic-health-examination screening program in military personnel enabled not only discovery of patient with newfound arterial hypertension but also regular monitoring of those who are already on antihypertensive therapy, significant savings of €690.58 per patient and €2,026.67 per patient can be achieved, respectively. As financial resources for providing health care in Serbia, as a middle-income country, are limited, further efforts should be put on screening programs for ischemic heart disease due to possible significant savings.

Who Gets Lost: Follow-up of Suspect Results in a Newborn Screening Program

PEDIATRICS ◽  
1998 ◽  
Vol 102 (2) ◽  
pp. e21.2-e21
Author(s):  
Donald W. Spady ◽  
L. Duncan Saunders ◽  
Fiona Bamforth
Keyword(s):  
Newborn Screening ◽  
Screening Program ◽  
Newborn Screening Program

PUBLIC PRESENTATIONS

PEDIATRICS ◽  
1989 ◽  
Vol 83 (5) ◽  
pp. 910-910
Author(s):  
Deborah D. Henry
Keyword(s):  
New York ◽  
New York City ◽  
Sickle Cell Disease ◽  
Newborn Screening ◽  
Sickle Cell ◽  
York City ◽  
Screening Program ◽  
Newborn Screening Program ◽  
Cell Disease

I am the parent of an 11½-year-old daughter with sickle cell disease. I am aware of the need for a comprehensive newborn screening program for sickle cell disease and other hemoglobinopathies. However, all such programs must be instituted with a follow-up component, and parents should be made aware that such screenings are being done. My daughter was born during the summer of 1975 in New York City. New York City began screening for sickle cell and similar hemoglobinopathies in May 1975, but had no comprehensive follow-up program until 1978. My daughter was not screened nor was I aware of the screening program. I learned of my daughter's condition during a routine well-child clinic visit when she was 6 months of age. I am afraid to think of her outcome had I not been taking her for preventive health care, because before the age of 1 year she experienced one of the most life-threatening crises of a child with sickle cell disease—splenic sequestration. I am pleased to announce that in New York City today, parents are notified in a timely manner of their infant's newborn screening results with information regarding follow-up and counseling services. Two of my immediate family members gave birth to infants with sickle cell trait. They were informed of their infants' results within 2 weeks after their babies' births, and were given concrete information and recommendations for follow-up genetic services. I know a comprehensive newborn screening program will prevent mortality in infants found to have sickle cell disease and related hemoglobinopathies.

Unexpected Finding from a PKU Newborn Screening Program

PEDIATRICS ◽  
1964 ◽  
Vol 34 (6) ◽  
pp. 889-890 ◽  
Author(s):  
R. WENDELL COFFELT
Keyword(s):  
Newborn Screening ◽  
Screening Program ◽  
Unexpected Finding ◽  
Maternal Phenylketonuria ◽  
Newborn Screening Program ◽  
The Third ◽  
Doctor's Office

We wish to draw attention to the unexpected finding of a maternal phenylketonuria case from our Guthrie PKU newborn screening program here in Burbank, California. The first specimen taken from the infant involved was on the third day of life and registered 6 mg/100 ml phenylalanine content in the blood. This occurred very early in our program and at that time we did not feel an immediate follow-up should be done unless the result appeared above 6 mg/100ml. The next specimen was taken when the baby was 6 weeks old routinely in the doctor's office.

Follow-up of Children With Trait in an Urban Setting

PEDIATRICS ◽  
1989 ◽  
Vol 83 (5) ◽  
pp. 878-878
Author(s):  
Lindsey K. Grossman ◽  
Neil A. Holtzman ◽  
Evan Charney ◽  
Allen D. Schwartz
Keyword(s):  
Genetic Counseling ◽  
Newborn Screening ◽  
Screening Program ◽  
Urban Setting ◽  
Newborn Screening Program ◽  
Screening Programs ◽  
Before And After

In a newborn screening program for abnormal hemoglobins, 91 infants were found to have hemoglobin AS or AC. Their parents were informed and offered genetic counseling, but only 350 accepted. We tested parents' knowledge of sickle disorders before and after the session. The tests were repeated when their babies were 4 to 8 months of age; parents of babies with normal hemoglobin and those with sickle trait who had not been counseled were also tested at this time. Parents who received counseling showed an increase in knowledge and retained it until the second interview, although 27% did not recall the original session. Noncounseled parents of a child with trait also had knowledge of the condition; in general, families of a child with trait knew more about the condition than families of a child without trait. Newborn hemoglobin screening programs prove helpful for certain families but not necessarily for all who may be eligible. (Previously published in Am J Dis Child 1985;139:241-244.)

Workplace intervention programmes for decreasing alcohol use in military personnel: a systematic review

2020 ◽  
pp. bmjmilitary-2020-001584
Author(s):  
Jason R Watterson ◽  
B Gabbe ◽  
J V Rosenfeld ◽  
H Ball ◽  
L Romero ◽  
...  
Keyword(s):  
Systematic Review ◽  
Alcohol Use ◽  
Military Personnel ◽  
Data Extraction ◽  
Experimental Studies ◽  
Active Duty ◽  
Active Duty Military ◽  
Quasi Experimental ◽  
The Military

IntroductionHarmful or risky-single occasion drinking (RSOD) alcohol use in the military is a significant problem. However, most studies of interventions have focused on veterans, representing a missed opportunity for intervention with active military personnel. Using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) framework, the aim of this systematic review was to analyse and synthesise the evidence related to workplace-based interventions for reducing alcohol use in active-duty military personnel.MethodsFour electronic databases and reference lists of relevant articles were searched from database inception until 20 January 2020. This review focused on experimental and quasi-experimental studies of active-duty military personnel. Data extraction and methodological quality assessment were independently performed by two reviewers using a standardised checklist. A third reviewer was used to arbitrate the disputed studies for final selection.ResultsThe search yielded seven studies from an initial 1582 records identified. A range of interventions were used in these studies (four randomised controlled trials, two non-randomised trials and one before and after cohort study), including web-based approaches, telephone-delivered interventions and individual and group-based face-to-face interventions. Seven studies found decreased drinking, measured using a range of outcomes, following the intervention. However, this was not sustained in the longer term in any of the studies.ConclusionsThe low methodological rigour of most studies limited the capacity to demonstrate the efficacy of the interventions studied. Given the importance of reducing harmful or RSOD use of alcohol in the military, future studies would benefit from improved methodological rigour including ensuring adequate study power, randomisation, selection of validated outcome measures, including measures other than consumption (eg, attitudinal measures), and longer-term follow-up. There is also a need to develop methods that ensure participant loss to follow-up is minimised.

Sign in / Sign up

Export Citation Format

Share Document